Fifty 1 Labs and All-In-Extracts, a wholly owned subsidiary of Royal Biotek Enterprises, have entered a joint venture to develop and release a new testosterone boosting supplement.
All-In-Extracts provides botanical extracts and Fifty 1 Labs serves the sports supplement, fitness equipment, and health and wellness sectors.
The supplement will be launched through Fifty 1 Labs’ wholly-owned subsidiary, 51 Labs. Clinical trials for this product are scheduled to commence soon.
According to Fifty 1 Labs, the product is designed to support natural testosterone production and enhance overall well-being for both men and women.
The joint venture merges both companies’ scientific research and advanced extraction techniques.
It will combine Fifty 1 Labs’ expertise in supplement formulation with All-In-Extracts’ botanical extraction methods to ensure that the product is scientifically robust and naturally potent.
The testosterone-boosting supplement will feature a blend of natural ingredients, chosen for their potential to elevate testosterone levels and promote vitality.
Fifty 1 Labs have selected these ingredients based on research and clinical evidence supporting their effectiveness.
Fifty 1 Labs CEO Robert Clark said: “Starting clinical trials promptly demonstrates our commitment to bringing a safe, effective, and high-quality product to the market.
“This joint venture allows us to leverage our combined expertise and resources to create something truly remarkable.”
Both firms will start clinical trials to ensure the product’s safety, efficacy, and quality.
These trials will follow scientific protocols, and the results will inform the final formulation and dosage.
The new testosterone-boosting supplement is designed to address common issues such as low energy levels, reduced muscle mass, and diminished libido.
By supporting natural testosterone production, the supplement aims to improve overall health and vitality in both men and women.
Pending successful trials, the product is scheduled for market release in Q4 2024, with an initial launch in the US and subsequent expansion internationally.
The companies are also preparing a marketing campaign to aware consumers of the benefits of this new supplement.
All-In-Extracts CEO Matthew Grisham said: “We are confident that our combined efforts will result in a product that will significantly benefit the health of men and women.”
